Latest Cardiac surgery Stories
ABBOTT PARK, Ill., March 20, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted by majority (Yes: 5, No: 3) that the benefits of treatment with the MitraClip(®) device outweigh its risks in patients with significant symptomatic mitral regurgitation (MR) who have been determined by a cardiac surgeon to be too high risk for open mitral valve...
Dr. Alex Zapolanski, a Board Certified Ridgewood, NJ physician specializing in Thoracic & Cardiac Surgery, has been selected by Castle Connolly Medical Ltd. for inclusion in its authoritative guide to the top primary care and specialty care doctors in the tri-state metropolitan New York area. RIDGEWOOD, N.J., March 13, 2013 /PRNewswire-USNewswire/ -- Castle Connolly Medical Ltd., America's trusted source for identifying Top Doctors, has published the 16th edition of Top Doctors:...
Catheter-delivered aortic valve durable at 3 years All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to results from the PARTNER study presented today at the American College of Cardiology's 62nd Annual Scientific Session. The transcatheter aortic valve replacement (TAVR) system was investigated as an alternative to...
Study suggests on-site surgery services unnecessary for patient safety in non-emergency angioplasty Non-emergency angioplasty performed at hospitals without on-site cardiac surgery capability is no less safe and effective than angioplasty performed at hospitals with cardiac surgery services, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Emergency surgery has become an increasingly rare event following percutaneous coronary...
The first multicenter study of hybrid revascularization shows that the emerging procedure for treating coronary artery disease has a similar rate of major adverse events in the first year, compared with percutaneous intervention (stenting). Hybrid revascularization is a minimally invasive blend of coronary bypass surgery and stenting. It has been described as a "best of both worlds" strategy for treating multi-vessel coronary artery disease. Surgeons avoid opening the patient's sternum,...
SAN FRANCISCO, March 10, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort evaluating the company's first-in-class catheter-based MitraClip(®) System for the treatment of mitral regurgitation (MR). Findings were presented today at the 62nd Annual Scientific Session of the American College of Cardiology in San Francisco. Abbott's MitraClip system, an investigational device in the...
DUBLIN, March 8, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fhjghw/transcatheter) has announced the addition of the "TransCatheter Aortic Valves Market" report to their offering. The global transcatheter aortic heart valve opportunity continues to be strong and growing. Edwards reported 2012 sales of $552 and predicts it will manage to generate $780 million globally in 2013, including $420 million in the US alone. Our analysts...
Third European Multi-Center Study Validating Earlier Compelling Results KIRKLAND, Wash., March 8, 2013 /PRNewswire/ -- Cardiac Dimensions(®),( )Inc. today announced that it has completed enrollment in its TITAN II clinical trial, a follow-up to the landmark TITAN clinical trial of the Company's CARILLON(® )Mitral Contour System(®). TITAN II is a prospective, single-arm European multi-center clinical trial initiated to further evaluate an enhanced version of the...
Bob Phillips Discharged from Penn State Hershey Medical Centerto Wait for a Matching Donor Heart at Home TUCSON, Ariz., March 7, 2013 /PRNewswire/ -- For 73 years, Bob Phillips was nothing but healthy. So healthy in fact, that he hadn't seen a doctor for 25 years. He never suspected that at age 74, he would become the oldest patient in the U.S. and the first in Pennsylvania to leave the hospital without a human heart. (Photo: http://photos.prnewswire.com/prnh/20130307/LA72741) "I...
New technology can save lives for those suffering from end-stage bi-ventricular heart failure NEW ORLEANS, Feb. 27, 2013 /PRNewswire/ -- The John Ochsner Heart & Vascular Institute (JOHVI) at Ochsner Medical Center has performed the Gulf South Region's first Total Artificial Heart (TAH) implant. The latest advancement in mechanical heart technology, the SynCardia TAH is the world's first and only FDA approved device. (Logo:...
Latest Cardiac surgery Reference Libraries
The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...
